Guest authorship, mortality reporting, and integrity in rofecoxib studies - Reply

Catherine D. DeAngelis; Phil B. Fontanarosa

doi:10.1001/jama.300.8.905

Guest authorship, mortality reporting, and integrity in rofecoxib studies - Reply

Catherine D. DeAngelis
, Phil B. Fontanarosa

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	905-906
Number of pages	2
Journal	JAMA
Volume	300
Issue number	8
DOIs	https://doi.org/10.1001/jama.300.8.905
State	Published - Aug 27 2008
Externally published	Yes

ASJC Scopus subject areas

General Medicine

Access to Document

10.1001/jama.300.8.905

Cite this

@article{89d664c77c8644a48550555c969947ec,

title = "Guest authorship, mortality reporting, and integrity in rofecoxib studies - Reply",

author = "DeAngelis, \{Catherine D.\} and Fontanarosa, \{Phil B.\}",

year = "2008",

month = aug,

day = "27",

doi = "10.1001/jama.300.8.905",

language = "English (US)",

volume = "300",

pages = "905--906",

journal = "JAMA",

issn = "0098-7484",

publisher = "American Medical Association",

number = "8",

}

TY - JOUR

T1 - Guest authorship, mortality reporting, and integrity in rofecoxib studies - Reply

AU - DeAngelis, Catherine D.

AU - Fontanarosa, Phil B.

PY - 2008/8/27

Y1 - 2008/8/27

UR - https://www.scopus.com/pages/publications/50449089848

UR - https://www.scopus.com/pages/publications/50449089848#tab=citedBy

U2 - 10.1001/jama.300.8.905

DO - 10.1001/jama.300.8.905

M3 - Letter

AN - SCOPUS:50449089848

SN - 0098-7484

VL - 300

SP - 905

EP - 906

JO - JAMA

JF - JAMA

IS - 8

ER -

Guest authorship, mortality reporting, and integrity in rofecoxib studies - Reply

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this